In an adult with chloride 121 mmol/L, CO₂ 11.4 mmol/L, BUN 47 mg/dL, and creatinine 0.67 mg/dL, what is the most likely cause of the metabolic acidosis and how should it be initially managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Severe Metabolic Acidosis in CKD: Diagnosis and Management

This patient has severe metabolic acidosis (CO₂/bicarbonate 11.4 mmol/L) most likely due to chronic kidney disease with acute decompensation, and requires immediate intravenous sodium bicarbonate therapy while investigating for concurrent acute processes.

Diagnostic Interpretation

Laboratory Analysis:

  • The CO₂ of 11.4 mmol/L represents serum bicarbonate and indicates severe metabolic acidosis requiring urgent intervention 1
  • Chloride 121 mmol/L is elevated (normal 99-110 mmol/L), suggesting a hyperchloremic component 2
  • BUN 47 mg/dL with creatinine 0.67 mg/dL shows a disproportionately elevated BUN:creatinine ratio (>20:1), indicating either volume depletion or increased protein catabolism from the acidosis itself 3
  • The low creatinine (0.67 mg/dL) may reflect muscle wasting from chronic metabolic acidosis rather than normal kidney function 1

Calculating the Anion Gap:

  • Anion gap = Na⁺ - (HCO₃⁻ + Cl⁻) = Na⁺ - (11.4 + 121) = Na⁺ - 132.4 1
  • Without the sodium value, we cannot definitively determine if this is a pure normal anion gap acidosis or a mixed picture 1
  • The elevated chloride (121 mmol/L) strongly suggests a hyperchloremic (normal anion gap) component 2, 4

Most Likely Etiologies

Primary Cause - CKD with Acute Decompensation:

  • CKD impairs hydrogen ion excretion and ammonia synthesis, causing acid accumulation 3
  • Bicarbonate <18 mmol/L indicates CKD stage 3-5 with inadequate treatment of chronic metabolic acidosis 1
  • The severity (11.4 mmol/L) suggests an acute-on-chronic process 3

Contributing Factors to Investigate:

  • Volume depletion: The elevated BUN:creatinine ratio and high chloride suggest prerenal azotemia with hyperchloremic acidosis 5, 2
  • Diarrhea or GI losses: Can cause bicarbonate loss producing normal anion gap acidosis 1
  • High-output stoma: If post-surgical, can cause massive bicarbonate depletion 5
  • Excessive saline administration: Large-volume 0.9% NaCl causes hyperchloremic acidosis 1, 5

Immediate Management Protocol

Step 1: Obtain Arterial Blood Gas

  • Measure pH and PaCO₂ to confirm metabolic acidosis (pH <7.35), quantify severity, and assess respiratory compensation 3
  • Check serum lactate to exclude lactic acidosis from tissue hypoperfusion 3
  • Obtain complete electrolytes including sodium to calculate anion gap 1

Step 2: Initiate Intravenous Bicarbonate Therapy

  • Administer IV sodium bicarbonate immediately for bicarbonate 11.4 mmol/L, as this represents severe metabolic acidosis 3
  • Initial dosing: 2-5 mEq/kg body weight over 4-8 hours 3
  • Target: Increase bicarbonate toward 18-20 mmol/L initially, not to normal range 1
  • Monitor arterial blood gases every 1-2 hours initially to assess pH response 3

Step 3: Fluid Resuscitation Strategy

  • If volume depleted: Start with isotonic saline (0.9% NaCl) at 15-20 mL/kg/h for the first hour to restore renal perfusion 1
  • Switch to balanced crystalloids (Lactated Ringer's or Plasma-Lyte) after initial resuscitation to avoid worsening hyperchloremic acidosis 1, 5
  • Discontinue any ongoing 0.9% saline immediately to halt further chloride-induced acidosis 5

Step 4: Critical Monitoring

  • Check serum potassium every 2-4 hours during bicarbonate therapy, as alkalinization drives potassium intracellularly and can cause life-threatening hypokalemia 3, 1
  • Monitor serum electrolytes (Na⁺, K⁺, Cl⁻, HCO₃⁻) every 2-4 hours 1
  • Reassess BUN and creatinine to track renal function response 3

Long-Term Management After Stabilization

Maintenance Therapy:

  • Target serum bicarbonate ≥22 mmol/L at all times to prevent protein catabolism, bone disease, and CKD progression 3, 1
  • Oral sodium bicarbonate: 2-4 g/day (25-50 mEq/day) divided into 2-3 doses for chronic management once acute crisis resolved 3, 2
  • Monitor bicarbonate monthly initially, then every 3-4 months once stable 1

Dietary Modifications:

  • Increase fruit and vegetable intake to provide potassium citrate salts that generate alkali 1
  • This approach may provide additional benefits including reduced blood pressure and weight loss compared to bicarbonate alone 1

Common Pitfalls to Avoid

Critical Errors:

  • Delaying bicarbonate therapy: Bicarbonate 11.4 mmol/L requires immediate treatment; waiting for complete workup risks worsening protein catabolism and cardiac dysfunction 3
  • Continued normal saline administration: Perpetuates hyperchloremic acidosis and impairs renal blood flow 1, 5
  • Ignoring potassium monitoring: Rapid alkalinization without potassium replacement can precipitate fatal arrhythmias 3, 1
  • Over-correction: Target bicarbonate 18-20 mmol/L acutely, not normalization, to avoid rebound alkalosis 1

Diagnostic Oversights:

  • Assuming normal kidney function from low creatinine: The creatinine 0.67 mg/dL likely reflects muscle wasting from chronic acidosis, not preserved GFR 1
  • Missing concurrent high anion gap component: Always calculate anion gap once sodium is available to detect mixed disorders 1
  • Overlooking GI losses: Specifically ask about diarrhea, vomiting, or stoma output as reversible causes 5, 1

References

Guideline

Acid-Base Disorders and Bicarbonate Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Metabolic Acidosis Management in Chronic Kidney Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Normal Anion‑Gap Metabolic Acidosis in Post‑Operative Patients with High‑Output Stomas

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.